Ecolab tightens hold on US hygiene sector with Microtek buy:
This article was originally published in Clinica
US provider of cleaning and pest control services to hospitals Ecolab is to consolidate its business in the healthcare sector with the acquisition of Microtek Medical. The deal, which is expected to close in the fourth quarter of 2007, will see Ecolab (St Paul, Minnesota) pay $6.30 per share (approximately $274m in total) for all outstanding shares in the infection control and safety products manufacturer. The purchase of Alpharetta, Georgia-based Microtek is expected to reduce Ecolab's 2008 earnings by two cents per share, but will be accretive beyond that. Ecolab reiterated its forecasts to earn $1.64-1.66 per share for 2007.
You may also be interested in...
Feature: Public Health England has revealed it is only a week away from approving a COVID-19 antibody test for distribution via Amazon. HBW Insight looks at the race to place the first, government-approved coronavirus home-test on the UK market.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.